CyberArk Software’s (CYBR) “Buy” Rating Reaffirmed at DA Davidson
otakuyassine3@gmail.com DA Davidson restated their buy rating on shares of CyberArk Software (NASDAQ:CYBR – Free Report)...
Reaffirmed
Vertex Pharmaceuticals’ (VRTX) “Overweight” Rating Reaffirmed at Cantor Fitzgerald
Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report)‘s stock had its “overweight” rating restated by stock...
Norfolk Southern’s (NSC) Buy Rating Reaffirmed at Benchmark
Benchmark reiterated their buy rating on shares of Norfolk Southern (NYSE:NSC – Free Report) in...
Danaher’s (DHR) “Outperform” Rating Reaffirmed at Royal Bank of Canada
Danaher (NYSE:DHR – Get Free Report)‘s stock had its “outperform” rating reaffirmed by research analysts...
Netflix’s (NFLX) “Outperform” Rating Reaffirmed at Wedbush
Netflix (NASDAQ:NFLX – Get Free Report)‘s stock had its “outperform” rating reiterated by stock analysts...
Simulations Plus’ (SLP) “Outperform” Rating Reaffirmed at William Blair
Simulations Plus (NASDAQ:SLP – Get Free Report)‘s stock had its “outperform” rating reissued by analysts...
Rhythm Pharmaceuticals’ (RYTM) Buy Rating Reaffirmed at HC Wainwright
Rhythm Pharmaceuticals (NASDAQ:RYTM – Get Free Report)‘s stock had its “buy” rating restated by analysts...